Coating of human decay accelerating factor (hDAF) onto medical devices to improve biocompatibility

This publication has 22 references indexed in Scilit:

• Effects of inhibition of complement activation using recombinant soluble complement receptor 1 on neutrophil CD11b/CD18 and l-selectin expression and release of interleukin-8 and elastase in simulated cardiopulmonary bypass
  The Journal of Thoracic and Cardiovascular Surgery, 1996
• Surface-bound heparin—Panacea or peril?
  The Annals of Thoracic Surgery, 1994
• Complement inhibition with soluble complement receptor type 1 in cardiopulmonary bypass
  The Annals of Thoracic Surgery, 1993
• Complement Activation Produced by Biomaterials
  Artificial Organs, 1988
• Structure, Organization, and Regulation of the Complement Genes
  Annual Review of Immunology, 1988
• Activation of the complement system at the interface between blood and artificial surfaces
  Biomaterials, 1988
• Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes.
  The Journal of Experimental Medicine, 1984
• Complement Activation during Cardiopulmonary Bypass
  New England Journal of Medicine, 1981
• Chemical Cross-Linking in Biology
  Annual Review of Biophysics and Bioengineering, 1979
• Inhibition of complement by a substance isolated from human erythrocytes — I: Extraction from human erythrocyte stromata
  Immunochemistry, 1969